{
  "id": 6752312,
  "title": "Takeda's R&D chief Andy Plump to retire; Novo Nordisk appoints global research head",
  "url": "https://urgent.news/2026/09/11/takedas-r-d-chief-andy-plump-to-retire-novo-nordisk-appoints-global",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-11T11:00:06.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/takedas-r-novo-nordisk-appoints-global-research-head/"
  },
  "original_language": "en",
  "account": null,
  "summary": "→ As Takeda celebrates a pair of FDA approvals, one of its top execs will be retiring in June 2027. Andy Plump joined Takeda from Sanofi in 2015, and has led R&D since December 2018 ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "STAT News",
        "title": "STAT+: Pharmalittle: We’re reading about another Novartis trial failure, a Novo Nordisk setback, and more",
        "url": "https://urgent.news/2026/09/08/stat-pharmalittle-were-reading-about-another-novartis-trial-failure-a",
        "published": "2026-09-08T13:26:51.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}